Home/Nanologica/Eva Osterman
EO

Eva Osterman

Chief Financial Officer

Nanologica

Therapeutic Areas

Nanologica Pipeline

DrugIndicationPhase
NLAB Saga® Silica MediaPurification of Peptide Drugs (e.g., Insulin, GLP-1)Commercial
Chromatography Consumables DevelopmentNew applications for complex moleculesR&D
Syntagon CDMO ServicesSmall molecule & peptide manufacturingCommercial